AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading ABBV News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
-1.32%31.150.8%$979.52m
JNJJohnson & Johnson
-0.78%111.190.7%$892.89m
MRKMerck & Co., Inc.
-0.51%59.970.8%$626.19m
BMYBristol-Myers Squibb Company
-2.05%54.880.9%$598.57m
LLYEli Lilly and Company
-0.91%67.180.6%$558.55m
ABBVAbbVie, Inc.
-2.56%60.042.2%$531.86m
NVSNovartis AG Sponsored ADR
-0.61%68.540.1%$233.09m
AZNAstraZeneca PLC Sponsored ADR
-0.54%25.871.2%$211.60m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.26%35.170.2%$185.53m
GSKGlaxoSmithKline plc Sponsored ADR
-0.19%37.620.3%$168.08m
SNYSanofi Sponsored ADR
-0.25%40.560.2%$79.96m
LCILannett Company, Inc.
-4.09%23.4525.1%$25.21m
SCMPSucampo Pharmaceuticals, Inc. Class A
-3.48%15.254.3%$10.17m
AKTXAkari Therapeutics Plc Sponsored ADR
0.00%7.510.2%$0.03m
EPIXESSA Pharma Inc
-1.75%2.250.0%$0.01m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.